Glutamate receptor subunit 4 (GluA4) is highly expressed by neural cells sensitive to excitotoxicity, and is the predominant subunit expressed by oligodendrocyte precursor cells (OPC) during a key period of vulnerability to hypoxic-ischemic injury. Therefore, transcriptional networks downstream of excitotoxic GluA4 activation represent a promising area for therapeutic intervention. In this work, we identify the CCAAT binding transcription factor NF-Yb as a novel transcriptional regulator of Gria4 (GluA4 gene), and a controller of excitotoxic death in the oligodendroglial lineage. We describe a novel regulatory region within Gria4 containing CCAAT sequences whose binding by NF-Yb is regulated by excitotoxicity. Excitotoxicity-induced alterations in NF-Yb binding are associated with changes in Gria4 transcription, while knockdown of NF-Yb alters the transcription of reporter constructs containing this regulatory region. Data from immortalized and primary OPC reveal that RNAi and pharmacological disruption of NF-Yb alter Gria4 transcription, with the latter inducing apoptosis and influencing a set of apoptotic genes similarly regulated during excitotoxicity. These data provide the first definition of a trans-acting mechanism regulating Gria4, and identify the NF-Y network as a potential source of pharmacological targets for promoting OPC survival.
. These observations suggest that a substantial number of OPC AMPAR lack GluA2 subunits since inclusion of this subunit limits the permeability of AMPAR to Ca 21 (Geiger et al., 1995; Hollmann, Hartley, & Heinemann, 1991) . In support of this, cultured OPC express high levels of GluA3 and 4 (Hossain et al., 2014; Itoh et al., 2002) which may assemble to form Ca 21 permeable AMPAR, and GluA4 is the predominant subunit expressed by OPC in the developing white matter of rodents and humans . Importantly, the timing of GluA4 expression in these systems corresponds with an established window of vulnerability during which OPC are selectively injured by hypoxicischemic conditions (Back et al., 2002; Back et al., 2001 ; reviewed in Fern, Matute, & Stys, 2014) , and GluA4 is highly expressed in neural cells vulnerable to excitotoxic cell death (Page & Everitt, 1995) . GluA4 signalling is therefore strongly connected to excitotoxicity.
Excitotoxic injury induces OPC and oligodendrocyte cell death through stress-induced apoptotic pathways involving the Bcl-2 family (Ness, Romanko, Rothstein, Wood, & Levison, 2001; Ness, Scaduto, & Wood, 2004; Sanchez-Gomez, Alberdi, Ibarretxe, Torre, & Matute, 2003; Sanchez-Gomez, Alberdi, Perez-Navarro, Alberch, & Matute, 2011; Simonishvili, Jain, Li, Levison, & Wood, 2013) . These processes are tightly regulated by the expression of pro-and anti-apoptotic Bcl-2 genes (Kumar & Cakouros, 2004; Riley, Sontag, Chen, & Levine, 2008) , thus the transcriptional networks stimulated by excitotoxic injury represent promising targets for therapies aiming to reduce excitotoxic injury and cell death. In the context of OPC the transcriptional events associated with GluA4 are of particular interest due to its prominent expression in these cells, and its links to the induction of excitotoxic cell death (Page & Everitt, 1995; Santos et al., 2006) . Based on this premise we used an excitotoxic injury model in the Oli-neu cell line (Jung et al., 1995) and primary OPC (pOPC) to identify subunit B of the nuclear factor Y complex (NF-Yb) as a regulator of GluA4 transcription and cell survival in oligodendroglia. Using a combination of ChiP, qPCR, Western blot and reporter assays we show that excitotoxic AMPAR stimulation alters NF-Yb binding to a novel Gria4 regulatory region, leading to complementary alterations in the levels of GluA4 mRNA and protein. We also provide data highlighting the therapeutic potential of the NF-Y transcriptome, with siRNA and pharmacological-mediated disruption of the NFY pathway compromising oligodendroglial viability and regulating similar apoptotic genes to those influenced by excitotoxic injury.
| MATERIALS A ND METHODS

| Cell culture
Oli-neu cells were kindly provided by Prof Jacqueline Trotter (University of Mainz). Oli-neu cells were cultured in Sato medium containing 1%
horse serum (Trotter, Bitter-Suermann, & Schachner, 1989 ) and grown in 5% CO 2 at 378C. All experiments were carried out with cells at passage 5 after thawing. Cultures of pOPC were prepared from the neocortices of C57BL6/J mice aged 1-4 days using the protocol described by O'Meara, Ryan, Colognato, and Kothary (2011) . Mixed glial cultures were maintained for 9 days (5% CO 2 at 378C) in DMEM containing 10% FBS and insulin (2 mg/ml) before isolation of pOPC by the shake-off method. Isolated pOPC were seeded into poly-L-Lysine coated culture wells at a density of 1.0-5.0 3 10 5 cells/well and maintained in OPC medium. OPC medium consisted of DMEM:F12 supplemented with 1% N2, 1% B27, 2 mM L-Glutamine, 1% PC-ST, 20 ng/ml rhFGF2, 100 ng/ ml IGF1, 20 ng/ml PDGF-AA, and 3.6 ng/ml Hydrocortisone. pOPC cultures were used for experiments between 1 and 2 days in vitro.
| Drugs
Stock solutions of L-glutamate (100 mM, Sigma-Aldrich Company Ltd, Dorset, UK) and AMPA (100 mM, Abcam, Cambridge, UK) were prepared in distilled water, while cyclothiazide (CTZ, 100 mM, Bio-Techne Ltd/ R&D Systems, Abingdon, UK) and Garcinol (10 mM, Tocris Bioscience, Abingdon, UK) were prepared in DMSO. Drugs were diluted in Sato medium for application to Oli-neu cells or OPC medium for experiments using pOPC. AMPA was applied with CTZ (AMPA/CTZ; both at 100 mM)
for 5 hr to induce excitotoxicity (Alberdi et al., 2002) , or at 200 mM (without CTZ) for 24 hr for non-pathological AMPAR stimulation (AMPA 24h ; Yuan et al., 1998) . In experiments using pOPC CTZ was applied at 50 mM.
Garcinol was used at 10 mM for gene expression, Western blot, and ChIP experiments. This concentration was selected based on pilot studies examining treatment with log concentrations of Garcinol (1-1,000 mM), in which concentrations >10 mM caused catastrophic cell detachment and death (data not shown). BrdU (Sigma-Aldrich Company Ltd) stocks were prepared as described by Fannon et al. (2015) .
| Trypan blue cell viability assay
For viability assays Oli-neu were seeded into 6-well plates at a density of 5 3 10 5 cells/well, while pOPC were cultured in 12-well plates at a density of 5 3 10 4 cells/well. 24 hr after seeding cells were treated with L-glutamate, CTZ, or AMPA/CTZ for 5 hr, then trypsinized, stained with 0.04% trypan blue (Sigma-Aldrich) and counted on a haemocytometer to quantify % viability. Data were collected in triplicate from five independent cell cultures by an experimenter masked to the treatment.
| Antibodies
Antibodies used in this study are detailed in Supporting Information Table S1 . Specificity for immunopositive signals was determined in control samples incubated with secondary antibodies alone.
| Immunocytochemistry, plasma membrane labelling and imaging
Immunofluorescent staining was performed using a protocol previously used in our lab to label brain slices (Fannon et al., 2015 which preserved CellMask signal while allowing reasonable labeling of GluA4. GluA4 was then detected as described above, except for omission of Triton-X100 in the blocking and carrier solutions. Slides were imaged on an inverted microscope (Zeiss Axiovert 200, Zeiss, Oberkochen, Germany) equipped with a differential spinning disk confocal module as described previously (Fannon et al., 2015) . 
| Proliferation and apoptosis studies
Cells were seeded into 8-well chamber slides at a density of 3 3 10 5 and allowed to settle for 24 hr prior to treatment with AMPA/CTZ, followed by exposure to BrdU (10 mM) for 7 hr. For AMPA 24h experiments BrdU treatments were introduced during the last 7 hr of treatment. BrdU was detected as previously described (Fannon et al., 2015) and proliferation quantified as the % DAPI 
| GcCamp5 Ca 21 imaging
A recombinant Semlikiforest Virus (SFV) vector derived from strain A7
(74) was constructed to deliver GcAMP5 (Akerboom et al., 2012) to
Oli-neu cells (Ehrengruber et al., 2003; Fannon et al., 2015) . GcAMP5 cDNA (gift from Dr Lin Tian, University of California, Davis) was cloned into pSFV(A774nsP) and infectious SFV(A774nsP)-GcAMP5 (SFVGcAMP5) particles generated in BHK cells using method a described by Ehrengruber, Schlesinger, and Lundstrom (2011) . Oli-neu cells in 35 mm imaging dishes (MatTek Corporation, Ashland, MA) were infected by treatment with Sato medium containing a 1:100 dilution of the un-purified SFV-GcAMP5 preparation (7.86 3 10 5 infectious units/ ml, 1 hr, 378C/5% CO2). Cells were imaged the following day using the spinning disk module in confocal mode (203, 485 nm excitation filter, 560 nm emission filter). Cells were perfused with medium via a peristaltic pump enabling delivery and removal of CTZ and AMPA/CTZ solutions. Solutions within the imaging dish were maintained at 348C via an inline heater (Bioscience Tools, San Diego, CA) coupled to the perfusion setup. GcAMP5 signals were captured one frame/10 s through the following sequence: 5 min CTZ alone (baseline), 5 min AMPA/CTZ, 5 min CTZ alone. Mean signal intensity was measured using ImageJ (Schneider, Rasband, & Eliceiri, 2012) , and changes in GcAMP5 quantified by normalizing to the mean baseline fluorescence (DF/F).
| RNA and protein extraction
Five independent cultures of Oli-neu cells were seeded into T25
( Table S1 for details of antibodies).
| Chromatin immunoprecipitation (ChIP)
ChIP experiments quantifying NF-Yb binding to the Gria4 intronic regulatory region were performed in accordance with previously published methods (Weaver et al., 2004; Zhang et al., 2010) . Table S1 ) while antibodies against RNA POL and normal mouse IgG were used for positive and negative controls respectively. Samples were then prepared for DNA elution by hydrolysis of crosslinks and all inputdigested DNA and output DNA purified using the Qiaquick PCR purification kit (Qiagen). Ratios of output DNA:input DNA were determined by qPCR with the primers detailed in Supporting Information Table S2 . All
ChiP experiments were performed on triplicate samples derived from five independent Oli-neu cell cultures except for Garcinol treated groups where triplicate samples were assessed in four independent cultures.
| Luciferase assays
Reporter constructs containing either the 822 bp Gria4 regulatory sequence (wtGria4), or a version with NF-Y binding site mutations (DGria4, see Supporting Information Table S3 for 
| Transcriptome analysis
Transcriptomic profiling was carried out on extracted RNA (Qiagen, Crawley, UK) after the quality of RNA was assessed using an ND-1000 spectrophotometer (Nanodrop, Wilmington, DE) and qualified using an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA).
Agilent two color 60K Mouse microarrays were used to assess whole genome gene expression according to the manufacturer's instructions.
Control samples were labelled with Cy3 (green) and treated samples were labelled with Cy5 (red). For background correction, the linear models for microarray data (LIMMA) package (Ritchie et al., 2015) were used within R 3.3.2 (RCoreTeam, 2016). Normalization within arrays was conducted using the "Loess" function and normalization between arrays was conducted using the "Aquantile" function (Smyth & Speed, 2003) . The "lmscFit" function was used for separate channel analysis of two-color microarray data (Smyth & Altman, 2013) using BenjaminiHochberg to adjust p values.
2.14 | Analysis of gene expression network models String database was used to assess the integrity and connectivity of gene modules (Szklarczyk et al., 2015) .
| Data analysis and statistics
Normal distributions were tested using an online Shapiro-Wilks tool (Dittami, 2009 ) and when present two-group comparisons were made by t tests, and multiple comparisons examined by one-way ANOVA followed by Tukey's Honest Significance Difference post hoc tests.
Mann-Whitney U tests were used for two-group comparisons when non-normal distributions were detected. All comparisons were tested using the online tool VassarStats (Lowry, 2009) 
. Potential regulators of
Gria4 were identified by screening all known Gria4 interactions (Ingenuity Pathway Analysis, Qiagen, Redwood City, CA). A fixed value of p a < .05 for two-tailed tests was the criterion for reliable differences between groups. One-tailed tests were used when predictions were made possible by preceding results. Cited values are s 6 SEMs.
| RE SUL TS
| Expression of AMPAR subunits in oli-neu cells
Oli-neu cells are an established model for OPC (Jung et al., 1995; Pereira, Dobretsova, Hamdan, & Wight, 2011 ) previously used to study transcriptional regulation in oligodendroglia (Fratangeli et al., 2013) .
AMPAR expression has not been reported in Oli-neu cells so we used qPCR and immunocytochemistry to detect AMPAR subunits GluA1-4.
qPCR detected transcripts for all four GluA subunits (data not shown).
Using immunofluorescent labeling GluA1 expression was limited to a few cells in which expression was restricted to the nucleus (Supporting Information Figure S1ai , S1aii). In contrast, GluA2, 3, and 4 were expressed by all cells (GluA2-3, Supporting Information Figure S1bi Figure S2a ). These data suggest that functional calcium-permeable AMPAR are present at modest levels in Oli-neu cells. We examined the ability of these receptors to mediate pathological signaling events by exposing Oli-neu cells to AMPAR-stimulating treatments likely to induce excitoxicity. Log concentrations of L-glutamate (1-1,000 mM) applied for 5 hr reduced viability from 10 mM (Supporting Information Figure S2b ; ANOVA p < .0001, control vs. 10 mM p < .05, control vs. 100 mM p < .01, control vs.
1,000 mM p < .01). We also examined viability after a 5-hr exposure to AMPA/CTZ, which specifically and potently activates AMPAR without affecting other types of glutamate receptor. This treatment was more effective than L-glutamate, with effects observed at the lowest concentration (1 mM; Figure 1e ; ANOVA p < .0001, control vs. 1 mM p < .01, control vs. 10 mM p < .01, control vs. 100 mM p < .01, control vs.
1,000 mM p < .01). Importantly, the decrease in cell viability caused by AMPA/CTZ was blocked by pre-incubation in the selective AMPAR antagonist NBQX (Figure 1f ; ANOVA p < .01, AMPA/CTZ vs.
Prolonged stimulation with AMPA (200 mm) in the absence of CTZ inhibits OPC proliferation and differentiation without affecting viability (Yuan et al., 1998) . We used this treatment, designated here as AMPA 24h, to determine if Oli-neu cells are similarly sensitive to milder levels of AMPAR activation. AMPA 24h had no effect on Oli-neu cell proliferation (Supporting Information Figure S3a ; p 5 .83), or cell viability (Supporting Information Figure S3b ; p 5 .38), showing that AMPA only affected Oli-neu cells when co-treated with CTZ. Incubation with 100 mm AMPA/CTZ produced a reliable decrease in cell viability ( Figure   1e ), so this treatment was chosen for studies aiming to uncover mechanisms regulating GluA4 transcription during excitotoxic injury.
| Identifying transcriptional regulators of Gria4
An in silico approach designed to identify regulators of Gria4 transcription highlighted NF-Yb as a relevant target. Gria4 was previously identified in a large-scale screen of NF-Yb binding sites carried out in HEPG2 cells (Testa et al., 2005) . This information, together with its established role in controlling proliferation and cell death (Imbriano, Gnesutta, & Mantovani, 2012) Table S2 ). This region is located 3 0 to the transcription start site (TSS) and so falls outside of the classic proximal promoter position associated with CCAAT elements (Mantovani, 1999 ).
| Excitotoxic AMPAR stimulation decreased expression of NF-yb and GluA4
Prolonged activation of AMPAR in pOPC cultures has been shown to induce alterations in the expression of GluA4 protein (Hossain et al., 2014) . To probe possible mechanisms regulating Gria4 transcription, with these CCAAT sites, and if binding was modulated by excitotoxic injury. Treatment with AMPA/CTZ resulted in a significant reduction in NF-Yb enrichment at sites 1 (p < .0001; Figure 3a) and 2 (p < .01; Figure 3b ) but not site 3 (data not shown). In agreement with our analysis of Gria4 transcription (Supporting Information Figure S3 ), AMPA 24h treatment had no effect on NF- between NF-Yb and the nuclear co-activator protein p300 (Figure 4a ; Faniello et al., 1999) . Therefore, we used the p300 inhibitor Garcinol (Balasubramanyam et al., 2004) (Figure 4giii ,giv). The % of cleaved caspase-3 1 cells was 25% (Figure 4h) , suggesting caspase-3-dependent apoptosis.
| NF-yb knockdown reduced transcription of constructs containing the Gria4 regulatory region
To test the influence of NF-Y on the CCAAT-containing regulatory region we performed reporter assays on Oli-neu cells transfected with the wtGria4 construct (Supporting Information Table S3) Table S3 ). In contrast to NF-Yb knockdown, cells transfected with DGria4 exhibited a 27.6-fold increase in activity of the reporter compared with cells treated with the wtGluA4 construct (Figure 5d ; p < .01). ; rounded squares in Figure   7b ,c -Supporting Information Table S8 ). The shared network of 39 genes was more connected than expected by chance (p < .001) and a central element was identified (dashed blue ellipse in Figure 7b ,c) in which treatments induced identical differential gene expression. function alters the expression of a number of apoptotic genes.
| NF-yb regulates Gria4 expression and cell survival in primary OPC
Together, these data provide the first example of a trans-acting mechanism controlling Gria4 expression, and highlight the NF-Y pathway as a regulator of OPC viability and survival.
| Studying transcriptional regulation of AMPAR in oli-neu cells
Oli-neu cells have been used to study aspects of oligodendrocyte biology including myelin protein trafficking (Dhaunchak, Colman, & Nave, 2011; Trajkovic et al., 2006) , exosome release (Fr€ uhbeis et al., 2013) , and the expression and function of connexins (Sohl, Hombach, Degen, & Odermatt, 2013) and G protein coupled receptors (Fratangeli et al., 2013; Simon et al., 2016) . The ease of generating large, high purity, cultures of these cells, and their ease of transfection relative to pOPC, make them particularly useful for studies of transcript expression and regulation where large numbers of homogenous cells must be manipulated and harvested for mRNA and protein sampling (Gobert et al., 2009; Iacobas & Iacobas, 2010; Joubert et al., 2010) . In this regard, their utility as a model for OPC biology is further supported by data from the present study showing that alterations in NF-Y function induce produces similar effects on Gria4 transcription and cell viability in both Olie-neu and pOPC.
The expression and regulation of glutamate receptors has not been explored in Oli-neu cells, although this was examined in electrophysiological studies of the closely related cb-neu cell line (Jung et al., 1995) , in which the absence of membrane currents was reported following exogenous application of glutamate. In contrast, the present paper provides two independent lines of evidence (Ca 21 imaging and excitotoxic cell death) that suggest modest levels of functional AMPAR expression in Oli-neu. Despite these low levels of AMPAR function, Oli-neu cells proved useful for detecting excitotoxic changes in GluA4 subunit expression and the transcriptional machinery controlling these processes.
| Excitotoxicity-induced changes in Gria4 transcription in olie-neu and pOPC
Depending on the cell type examined, excitotoxic injury either decreased (Oli-neu) or increased (pOPC) transcription of Gria4. These data from pOPC reflect those from an in vivo study of GluA4 expression in neonatal rats exposed to hypoxia (Sivakumar, Ling, Lu, & Kaur, 2010) . Here, exposure to hypoxia that induces strong elevations in the concentration of extracellular glutamate is associated with a significant increase in GluA4 immunoreactivity within immature oligodendroglia.
The expression of Gria4 is regulated developmentally (Itoh et al., 2002; Hossain et al., 2014) , thus the direction of excitotoxicity-induced regulation of Gria4 in oligodendroglia may depend on maturational status.
Indeed, Oli-neu cells cultured under the conditions used in the present study exhibit low levels of immunoreactivity to anti-O4 (Toutouna et al., 2016) , suggesting that this cell line holds a more immature position in the lineage than pOPC, which typically exhibit strong anti-04 staining. This difference not withstanding, other aspects of the relationship between NF-Yb, Gria4 transcription and cell viability were validated in pOPC, supporting a role for NF-Yb in the regulation of Gria4 and cell survival in OPC.
| Characteristics of the intronic CCAAT regulatory region in mouse Gria4
The CCAAT box is a common promoter element occupying a position typically located between 260 and 2100 from the TSS (Mantovani, 1999) , where it exerts well-described actions on promoter activity (Dolfini, Gatta, & Mantovani, 2012) . Prior to the present work NF-Y had not been studied in oligodendroglia. However, CCAAT sites located in the promoter of protein zero, a key myelin gene in the peripheral nervous system, regulate protein zero transcription in Schwann cells (Brown & Lemke, 1997) . The CCAAT sites identified in the present paper are located 3 0 to the Gria4 TSS so fall outside of the proximal promoter region. These observations add to a growing body of evidence demonstrating roles for NF-Y outside of classic promoter regions. For example, a recent genome-wide mapping study revealed that 25% of NF-Y peaks are associated with distal enhancer regions (Fleming et al., 2013) .
In addition, expression arrays performed following NF-Ya inactivation revealed that 50% of differentially expressed genes exhibit NF-Y/DNA binding outside of promoter regions. The importance of NF-Y/ enhancer interactions have also been validated in vivo, where they are found to regulate tissue specific expression of Hoxb4 during embryonic development (Gilthorpe et al., 2002) .
Garcinol reduced cell viability, NF-Yb transcription and NF-Yb Gria4 interactions. (a) Model illustrating organization of the NF-Y complex, it's association with CCAAT sites, and regulation through Garcinol sensitive p300 (Faniello et al., 1999) . (b) Garcinol reduces Olineu cell viability. Cell viability normalized to the control treatment was reduced following a 5-hr treatment with Garcinol (10 mM; control 1.00 6 0.02, Garcinol 0.88 6 0.01). (c) Transcript levels for NF-Yb were significantly reduced by a 5-hr exposure to Garcinol (control 1.00 6 0.15, Garcinol 0.55 6 0.06). (d) Garcinol reduced levels of GluA4 transcripts (control 1.00 6 0.19, Garcinol 0.51 6 0.06). (e and f) Treatment with Garcinol disrupted binding of NF-Y to the Gria4 promoter. Top panels show RT-PCR gels for four independent experiments on sites 1 (e) and 2 (f). I, input signal; O, output signal; Con, control; G, Garcinol. Lower panels show quantification of NF-Yb enrichment at sites 1(e) and 2 (e). Enrichment of NF-Yb at both sites was significantly reduced following treatment with Garcinol at site 1 (control 1.00 6 0.25, Garcinol 0.16 6 0.08) and site 2 (control 1.00 6 0.19, Garcinol 0.25 6 0.12). binding proteins (C/EBPs), which have a well described ability to bind CCAAT boxes (Landschulz, Johnson, Adashi, Graves, & McKnight, 1988) . Irrespective of these possibilities, the knockdown, qPCR and ChIP experiments presented in this paper highlight NF-Yb as an effective regulator of Gria4 transcription.
| First trans-acting mechanism regulating GluA4: Implications for protective therapies
To our knowledge, the actions of NF-Yb reported in the present study describe the first trans-acting mechanism controlling GluA4 expression.
Earlier work examining the promoter of rat Gria4 described two potential regulatory regions (Borges, Myers, Zhang, & Dingledine, 2003) . The first was a long interspersed element (LINE) located 3.6-3.9 kb upstream from the translation start site (TSS), which was found to contain silencing elements. This work also identified several TSS in Rat
Gria4 located between 21,090 and 21,011. Importantly, the LINE silencing region is distant from these sites being 2-3 kb further upstream, and so contrasts greatly with the regulatory region we have described in mouse Gria4, which is located 3 0 of the TSS. The second regulatory region in Rat Gria4 contained a cluster of transcription factor sites (e.g., SP1, CAAT box, IK2, MRE) located close to the TSS (Borges et al., 2003) . Although the authors did not determine the influence of these sites on transcription directly, they suggested their involvement in directing neuronal selectivity since deletion of the 177 bp region containing them reduced transcription of Gria4 in neuronal, but not glial cultures.
New data from the present study indicate that NF-Y plays an important role in the response of oligodendroglia to cellular stress.
Both excitotoxic injury and a pro-apoptotic treatment with Garcinol initiated a change in NF-Y function that was tightly linked to alterations in Gria4 transcription. Reduced levels of GluA4 could protect oligodendrocytes from further injury by diminishing the supply of calciumpermeable subunits for assembly into AMPAR. In contrast, recent findings indicating a role for AMPAR subunits GluA2, 3, and 4 in OPC survival (Kougioumtzidou et al., 2017) suggest that an increase in Gria4 transcription, as observed in pOPC following excitotoxic treatment, may promote viability. Given this complexity, further studies are required to determine the potential of Gria4 modulation to promote OPC viability under excitotoxicity-inducing conditions such as hypoxicischemia (Follett et al., 2000) and CNS inflammation (Groom et al., 2003; Kanwar et al., 2004; Pitt et al., 2000) . Although appearing contradictory, these outcomes are consistent within the framework of NF-Y function discussed above, where roles in the regulation of both pro-and anti-apoptotic responses have been described (Gatta, Dolfini, & Mantovani, 2011 
| Involvement of NF-Y in CNS dysfunction
As discussed above our data suggest an important role for NF-Y function in OPC survival. This conclusion is complemented by studies indicating NF-Y deregulation as a contributor to neurodegenerative processes in several polyglutamine (polyQ) expansion diseases (Huang, Ling, Yang, Li, & Li, 2011; Katsuno et al., 2010; Yamanaka et al., 2008) .
In each case, disrupted NF-Y activity is associated with the accumula- (Groom et al., 2003; Kanwar et al., 2004; Pitt et al., 2000) .
In conclusion, this work identifies NF-Yb as a key controller of Gria4 expression in OPC. AMPA-type glutamate receptors exert a powerful influence on the development and survival of OPC (Fannon et al., 2015; Gallo et al., 1996; Kougioumtzidou et al., 2017; Yuan et al., 1998) , and are themselves under strong developmental regulation (Hossain et al., 2014; Itoh et al., 2002) , thus further work exploring the interplay between NF-Y function and OPC differentiation represent a promising line of enquiry for studies aiming to uncover novel mechanisms regulating myelination. This work also highlights the NF-Y system as an important regulator of OPC survival during excitotoxic injury.
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OPC are exquisitely vulnerable to hypoxic-ischemic conditions (Back
